Improvement of porous β-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application

Tissue Engineering - Part A.

Volumn 14, Issue 8, 2008, Pages 1305-1319

  Abarrategi, Ander ^a,b   Moreno Vicente, Carolina ^a   Ramos, Viviana ^b   Aranaz, Inmaculada ^a   Sanz Casado, José Vicente ^a   López Lacomba, José Luís ^a,c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Noricum SL Departamento de I+D   (Spain)

^c Instituto de Estudios Biofuncionales   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; BUILDING MATERIALS; CERAMIC MATERIALS; CHITIN; CHITOSAN; CIVIL AVIATION; CLADDING (COATING); FOURIER TRANSFORMS; IMAGING TECHNIQUES; MOLECULAR BEAM EPITAXY; SURGERY; TECHNOLOGY; TISSUE ENGINEERING; TRANSMISSION CONTROL PROTOCOL; X RAY ANALYSIS; X RAY DIFFRACTION ANALYSIS;

ALKALINE PHOSPHATASE ACTIVITY; AVERAGE DIAMETER; BIOACTIVE AGENTS; BIODEGRADABLE MATERIALS; BONE FORMATION; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE ENGINEERING; BONE TISSUES; CELL DIFFERENTIATION; CELLULAR RESPONSES; CHITOSAN FILMS; COATING PROPERTIES; ENERGY DISPERSIVE X-RAY ANALYSIS; FOURIER; IN-VIVO; INFRA-RED ANALYSIS; OSTEOINDUCTIVE PROPERTIES; PHYSICO-CHEMICAL PROPERTIES; POROUS DISTRIBUTION; RHBMP-2; TRANSMISSION ELECTRON; TRI-CALCIUM PHOSPHATES; X-RAY DIFFRACTION;

SCAFFOLDS;

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; CHITOSAN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SCAFFOLD PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BONE REGENERATION; BONE TISSUE; CELL DIFFERENTIATION; CELL LINEAGE; CERAMICS; ENZYME ACTIVITY; FILM COATING; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; OSSIFICATION; PHYSICAL CHEMISTRY; POROSITY; PRIORITY JOURNAL; PROTEIN STRUCTURE; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY; X RAY ANALYSIS; X RAY DIFFRACTION;

EID: 48749091334     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0229     Document Type: Article

References (73)

1. Yuan, H, Yang, Z, Li, Y, Zhang, X, de Bruijn, J, and de Groot, K. Osteoinduction by calcium phosphate biomaterials. J Mater Sci Mater Med 9, 723, 1998.
2. Dorozhkin, SV. Calcium orthophosphates. J Mater Sci 42, 1061, 2007.
3. LeGeros, RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 395, 81, 2002.
4. Heini, PF, and Berlemann, U. Bone substitutes in vertebroplasty. Eur Spine J 10, S205, 2001.
5. Hench, L. Bioceramics: from concept to clinic. J Am Ceram Soc 74, 1487, 1991.
6. Sanchez-Salcedo, S, Izquierdo-Barba, I, Arcos, D, and Vallet-Regi, M. In vitro evaluation of potential calcium phosphate scaffolds for tissue engineering. Tissue Eng 12, 279, 2006.
7. Peter, SJ, Nolley, JA, Widmer, MS, Merwin, JE, Yaszemski, MJ, Yasko, AW, Engel, PS, and Mikos, AG. In vitro degradation of a poly (propylene fumarate)/-tricalcium phosphate composite orthopaedic scaffold. Tissue Eng 3, 207, 1997.
8. Kim, SS, Park, MS, Gwak, SJ, Choi, CY, and Kim, BS. Accelerated bonelike apatite growth on porous polymer/ceramic composite scaffolds in vitro. Tissue Eng 12, 2997, 2006.
9. Babensee, JE, McIntire, LV, and Mikos, AG. Growth factor delivery for tissue engineering. Pharm Res 17, 497, 2000.
10. Wikesjo, UM, Qahash, M, Thomson, RC, Cook, AD, Rohrer, MD, Wozney, JM, and Hardwick, WR. rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 15, 194, 2004.
11. Seeherman, H, and Wozney, JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16, 329, 2005.
12. Kirker-Head, CA. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev 43, 65, 2000.
13. Abarrategi, A, Gutierrez, MC, Moreno-Vicente, C, Hortigüela, MJ, Ramos, V, López-Lacomba, JL, María L. Ferrer, ML, and del Monte, F. Multiwall carbon nanotube scaffolds for tissue engineering purposes. Biomaterials 29, 94, 2008.
14. Hoshino, M, Egi, T, Terai, H, Namikawa, T, and Takaoka, K. Repair of long intercalated rib defects using porous beta-tricalcium phosphate cylinders containing recombinant human bone morphogenetic protein-2 in dogs. Biomaterials 27, 4934, 2006.
15. Ruhe, PQ, Boerman, OC, Russel, FG, Mikos, AG, Spauwen, PH, and Jansen, JA. In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med 17, 919, 2006.
16. Ruhe, PQ, Kroese-Deutman, HC, Wolke, JG, Spauwen, PH, and Jansen, JA. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials 25, 2123, 2004.
17. Jingushi, S, Urabe, K, Okazaki, K, Hirata, G, Sakail, A, Ikenoue, T, and Iwamoto, Y. Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograft. J Orthop Sci 7, 490, 2002.
18. Liang, G, Yang, Y, Oh, S, Ong, JL, Zhengc, C, Junguo Ranc, J, Guangfu Yinc, G, and Dali Zhou, D. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice. Biomaterials 26, 4265, 2005.
19. Chen, WJ, Jingushi, S, Hirata, G, Matsumoto, Y, and Iwamoto, Y. Intramuscular bone induction by the simultaneous administration of recombinant human bone morphogenetic protein 2 and bisphosphonate for autobone graft. Tissue Eng 10, 1652, 2004.
20. Tsuruga, E, Takita, H, Itoh, H, Wakisaka, Y, and Kuboki, Y. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem (Tokyo) 121, 317, 1997.
21. Kuboki, Y, Jin, Q, and Takita, H. Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J Bone Joint Surg 83, 105, 2001.
22. Yuan, H, de Bruijn, JD, Zhang, X, van Blitterswijk, CA, and de Groot, K. Use of an osteoinductive biomaterial as a bone morphogenetic protein carrier. J Mater Sci Mater Med 12, 761, 2001.
23. Ohyama, T, Kubo, Y, Iwata, H, and Taki, W. Beta-tricalcium phosphate combined with recombinant human bone morphogenetic protein-2: a substitute for autograft, used for packing interbody fusion cages in the canine lumbar spine. Neurol Med Chir (Tokyo) 44, 234, 2004.
24. Niedhart, C, Maus, U, Redmann, E, Schmidt-Rohlfing, B, Niethard, FU, and Siebert, CH. Stimulation of bone formation with an in situ setting tricalcium phosphate/rhBMP-2 composite in rats. J Biomed Mater Res A 65, 17, 2003.
25. Seeherman, H, Li, R, Bouxsein, M, Kim, H, Li, XJ, Smith-Adaline, EA, Aiolova, M, and Wozney, JM. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a non-human primate model at multiple treatment times and concentrations. J Bone Joint Surg Am 88, 144, 2006.
26. Seeherman, HJ, Azari, K, Bidic, S, Leif Rogers, L, Li, XJ, Hollinger, JO, and Wozney, JM. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Joint Surg Am 88, 1553, 2006.
27. Ruhe, PQ, Boerman, OC, Russel, FG, Spauwen, PH, Mikos, AG, and Jansen, JA. Controlled release of rhBMP-2 loaded poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites in vivo. J Control Release 106, 162, 2005.
28. Ruhe, PQ, Hedberg, EL, Padron, NT, Spauwen, PH, Jansen, JA, and Mikos, AG. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am 85-A Suppl 3, 75, 2003.
29. Hoshino, M, Namikawa, T, Kato, M, Terai, H, Taguchi, S, and Takaoka, K. Repair of bone defects in revision hip arthroplasty by implantation of a new bone-inducing material comprised of recombinant human BMP-2, beta-TCP powder, and a biodegradable polymer: an experimental study in dogs. J Orthop Res 25, 1042, 2007.
30. Takahashi, Y, Yamamoto, M, and Tabata, Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Biomaterials 26, 4856, 2005.
31. Blumenthal, NM, Koh-Kunst, G, Alves, ME, Miranda, D, Sorensen, RG, Wozney, JM, and Wikesjö, UME. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon. J Periodontol 73, 1494, 2002.
32. Namikawa, T, Terai, H, Suzuki, E, Hoshino, M, Toyoda, H, Nakamura, H, Miyamoto, S, Takahashi, N, Ninomiya, T, and Takaoka, K. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model. Spine 30, 1717, 2005.
33. Kumar, MN, Muzzarelli, RA, Muzzarelli, C, Sashiwa, H, and Domb, AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104, 6017, 2004.
34. Khor, E, and Lim, LY. Implantable applications of chitin and chitosan. Biomaterials 24, 2339, 2003.
35. Muzzarelli, R, and Muzzarelli, C. Chitosan chemistry: relevance to the biomedical sciences. Adv Polym Sci 186, 151, 2005.
36. Rinaudo, M. Chitin and chitosan: properties and applications. Prog Polym Sci 31, 603, 2006.
37. Shi, C, Zhu, Y, Ran, X, Wang, M, Su, Y, and Cheng, T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 133, 185, 2006.
38. Klokkevold, PR, Vandemark, L, Kenney, EB, and Bernard, GW. Osteogenesis enhanced by chitosan (poly-N-acetyl glucosaminoglycan) in vitro. J Periodontol 67, 1170, 1996.
39. Muzzarelli, RA, Mattioli-Belmonte, M, Tietz, C, Biagini, R, Ferioli, G, Brunelli, MA, Fini, M, Giardino, R, Ilari, P, and Biagini, G. Stimulatory effect on bone formation exerted by a modified chitosan. Biomaterials 15, 1075, 1994.
40. Ohara, N, Hayashi, Y, Yamada, S, Kim, SK, Matsunaga, T, Yanagiguchi, K, and Ikeda, T. Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide. Biomaterials 25, 1749, 2004.
41. Matsunaga, T, Yanagiguchi, K, Yamada, S, Ohara, N, Ikeda, T, and Hayashi, Y. Chitosan monomer promotes tissue regeneration on dental pulp wounds. J Biomed Mater Res A 76, 711, 2006.
42. Di Martino, A, Sittinger, M, and Risbud, MV. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26, 5983, 2005.
43. Wang, X, Ma, J, Wang, Y, and He, B. Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements. Biomaterials 23, 4167, 2002.
44. Zhang, Y, Ni, M, Zhang, M, and Ratner, B. Calcium phosphate-chitosan composite scaffolds for bone tissue engineering. Tissue Eng 9, 337, 2003.
45. Li, Z, Yubao, L, Aiping, Y, Xuelin, P, Xuejiang, W, and Xiang, Z. Preparation and in vitro investigation of chitosan/nano-hydroxyapatite composite used as bone substitute materials. J Mater Sci Mater Med 16, 213, 2005.
46. Hu, Q, Li, B, Wang, M, and Shen, J. Preparation and characterization of biodegradable chitosan/hydroxyapatite nano-composite rods via in situ hybridization: a potential material as internal fixation of bone fracture. Biomaterials 25, 779, 2004.
47. Xu, HH, and Simon, CG, Jr. Fast setting calcium phosphate-chitosan scaffold: mechanical properties and biocompatibility. Biomaterials 26, 1337, 2005.
48. Lee, YM, Park, YJ, Lee, SJ, Ku, Y, Han, SB, Choi, SM, Klokkevold, PR, and Chung, CP. Tissue engineered bone formation using chitosan/tricalcium phosphate sponges. J Periodontol 71, 410, 2000.
49. Koping-Hoggard, M, Tubulekas, I, Guan, H, Edwards, K, Nilsson, M, Vå rum, KM, and Artursson, P. Chitosan as a nonviral gene delivery system: structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther 8, 1108, 2001.
50. Strand, SP, Danielsen, S, Christensen, BE, and Varum, KM. Influence of chitosan structure on the formation and stability of DNA-chitosan polyelectrolyte complexes. Biomacromolecules 6, 3357, 2005.
51. Freier, T, Koh, HS, Kazazian, K, and Shoichet, MS. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials 26, 5872, 2005.
52. Rao, SB, and Sharma, CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res 34, 21, 1997.
53. Dhiman, HK, Ray, AR, and Panda, AK. Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines. Biomaterials 25, 5147, 2004.
54. Chatelet, C, Damour, O, and Domard, A. Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials 22, 261, 2001.
55. Lopez-Lacomba, JL, Garcia-Cantalejo, JM, Sanz Casado, JV, Abarrategi, A, Correas Magana, V, and Ramos, V. Use of rhBMP-2 activated chitosan films to improve osseointegration. Biomacromolecules 7, 792, 2006.
56. Abarrategi, A, Civantos, A, Ramos, V, Sanz-Casado, J, and López-Lacomba, J. Chitosan film as rhBMP-2 carrier: delivery properties for bone tissue application. Biomacromolecules 9, 711, 2008.
57. Lopez-Lacomba, JL, Garcia-Cantalejo, JM, Sanz Casado, JV, and Ramos, V. Method for the production of chitosan-based films with enhanced cell adhering capacity, resulting product and application.[Patent] P200002057(PCT/ES01/00322), 2000.
58. Feldkamp, L, Davis, L, and Kress, J. Practical cone-beam algorithm. J Opt Soc Am 1, 612, 1984.
59. Jones, AC, Milthorpe, B, Averdunk, H, Limaye, A, Senden, TJ, Sakellariou, A, Sheppard, AP, Sok, RM, Knackstedt, MA, Brandwood, A, Rohner, D, and Hutmacher, DW. Analysis of 3D bone ingrowth into polymer scaffolds via micro-computed tomography imaging. Biomaterials 25, 4947, 2004.
60. Jones, JR, Poologasundarampillai, G, Atwood, RC, Bernard, D, and Lee, PD. Non-destructive quantitative 3D analysis for the optimisation of tissue scaffolds. Biomaterials 28, 1404, 2007.
61. van Lenthe, GH, Hagenmuller, H, Bohner, M, Hollister, SJ, Meinel, L, and Muller, R. Nondestructive micro-computed tomography for biological imaging and quantification of scaffold-bone interaction in vivo. Biomaterials 28, 2479, 2007.
62. Kwon, S, Jun, Y, Hong, S, Lee, I, Kim, H, and Won, Y. Calcium phosphate bioceramics with various porosities and dissolution rates. J Am Ceram Soc 85, 3129, 2002.
63. Metsger, DS, Rieger, MR, and Foreman, DW. Mechanical properties of sintered hydroxyapatite and tricalcium phosphate ceramic. J Mater Sci Mater Med 10, 9, 1999.
64. Gbureck, U, Grolms, O, Barralet, JE, Grover, LM, and Thull, R. Mechanical activation and cement formation of beta-tricalcium phosphate. Biomaterials 24, 4123, 2003.
65. Jinawath, S, and Sujaridworakun, P. Fabrication of porous calcium phosphates. Mater Sci Eng C 22, 41, 2002.
66. Wang, X, Fan, H, Xiao, Y, and Zhang, X. Mater Lett 60, 455, 2006.
67. Sous, M, Bareille, R, Rouais, F, Clément, D, Amédée, J, Dupuy, B, and Baquey, Ch. Cellular biocompatibility and resistance to compression of macroporous beta-tricalcium phosphate ceramics. Biomaterials 19, 2147, 1998.
68. Sun, R, Li, M, Lu, Y, and Wang, A. Immersion behavior of hydroxyapatite (HA) powders before and after sintering. Mater Charact 56, 250, 2006.
69. Leeuwenburgh, SC, Wolke, JG, Siebers, MC, Schoonman, J, and Jansen, JA. In vitro and in vivo reactivity of porous, electrosprayed calcium phosphate coatings. Biomaterials 27, 3368, 2006.
70. Leng, Y, Chen, J, and Qu, S. TEM study of calcium phosphate precipitation on HA/TCP ceramics. Biomaterials 24, 2125, 2003.
71. Katagiri, T, Yamaguchi, A, Komaki, M, Abe, E, Takahashi, N, Ikeda, T, Rosen, V, Wozney, JM, Fujisawa-Sehara, A, and Suda, T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127, 1755, 1994.
72. von Doernberg, MC, von Rechenberg, B, Bohner, M, Grünenfelder, S, van Lenthe, GH, Müller, R, Gasser, B, Mathys, R, Baroud, G, and Auer, J. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials 27, 5186, 2006.
73. Yuan, H, van Blitterswijk, CA, de Groot, K, and de Bruijn, JD. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. Tissue Eng 12, 1607, 2006.